ICPi | immune checkpoint inhibitors |
CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
PD-1 | programmed cell death protein 1 |
PD-L1 | programmed death-ligand 1 |
IRAEs | immune related adverse events |
CD | celiac disease |
AD | autoimmune disease |
TCR | T cell receptor |
tTG | tissue transglutaminase |
APCs | antigen presenting cells |
MHC | histocompatibility complex |